What happened
Sorrento Therapeutics (NASDAQ:SRNE), a clinical-stage biotech, is off to a strong start this week. The drugmaker’s shares are up by a healthy 42.6% in pre-market trading Monday morning.
Last Friday, Sorrento’s shares gained an astounding 158%…
Read More
